Source · Select Committees · Business and Trade Committee
Recommendation 7
7
Acknowledged
India-UK trade agreement brings no significant changes to India's IP regime.
Conclusion
The Committee concludes that the Agreement does not introduce significant changes to India’s intellectual property regime that are likely to support growth in UK pharmaceutical exports. At the same time, the Committee recognises India’s role as a major producer of generic medicines and the importance of retaining some flexibility within its IP framework. The Committee welcomes the establishment of the Working Group on Intellectual Property established under the Agreement. (Conclusion, Paragraph 64)
Government response summary AI-generated
The government states that the IP chapter goes beyond India's precedent in FTAs, supporting the economy through IP rights protection and enforcement. They will continue to advance this agenda through the Working Group on Intellectual Property Rights and a specialist Intellectual Property attaché in India.
Government Response
The government responded to this report on 17 April 2026. No passage in that response could be matched to this conclusion. Read the response document ↗